Advertisement
Canada markets closed

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7297
    -0.0023 (-0.31%)
     

  • CRUDE OIL

    82.93
    -0.43 (-0.52%)
     

  • Bitcoin CAD

    87,640.24
    -3,173.54 (-3.49%)
     

  • CMC Crypto 200

    1,388.71
    -35.39 (-2.48%)
     

  • GOLD FUTURES

    2,332.50
    -9.60 (-0.41%)
     

  • RUSSELL 2000

    1,996.73
    -5.91 (-0.30%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ

    15,712.75
    +16.11 (+0.10%)
     

  • VOLATILITY

    15.59
    -0.10 (-0.64%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • CAD/EUR

    0.6818
    -0.0018 (-0.26%)
     
MARKETS LIVE BLOG:

STOCKS SHED GAINS, TESLA SURGES DAY AFTER EARNINGS

Tesla shares jump after EV maker vows to speed up launch of more affordable models

Stocks in play: Cardiol Therapeutics Inc

Baystreet.ca

Announces the initiation of a Phase II open-label pilot study (NCT05494788), to investigate the tolerance, safety, and efficacy of CardiolRx™ in patients with recurrent pericarditis. In addition to standard safety assessments, the study is designed to evaluate improvement in objective measures of disease, and during an extension period, assess the feasibility of weaning concomitant background therapy including corticosteroids, while taking CardiolRx™. Cardiol Therapeutics Inc shares T.CRDL are trading up $0.06 at $1.07.

Read: